Switzerland - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes
Since 2014, Switzerland Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes grew 4.7% year on year. In 2019, the country was ranked number 1 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes with €1,048.7 Per Capita. Liechtenstein, Germany and Belgium respectively ranked number 2, 3 and 4 in this ranking. Latvia recorded the best 5 years average growth at +7.4% per year, while Greece witnessed the worst performance at -0.5% per year.
Loading...
| Date | Euros Per Capita |
|---|---|
| 2019 | 1,048.70 |
| 2018 | 1,022.51 |
| 2017 | 1,019.30 |
| 2016 | 1,012.02 |
| 2015 | 983.91 |
Download all data from 2010 to 2019
How does Switzerland rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes?
| # | 33 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Switzerland
|
1,048.70 | 2019 | +2.6 % | +4.7 % | View data |
| 2 |
#2
Liechtenstein
|
860.32 | 2019 | +3.0 % | +2.4 % | View data |
| 3 |
#3
Germany
|
668.01 | 2019 | +1.7 % | +3.2 % | View data |
| 4 |
#4
Belgium
|
606.09 | 2019 | +0.1 % | +2.9 % | View data |
| 5 |
#5
Luxembourg
|
593.97 | 2019 | +0.9 % | +0.8 % | View data |